CQC Regulated Regulated by Care Quality Commission (CQC) • Provider Reg: CRT1-29647872574
Thrombophilia Certified Laboratory

Thrombophilia Panel 3

Uncover hidden inherited risks behind abnormal blood clotting.

15 min
£400
305 Neasden Lane, London NW10 1QR, UK
Sample Collection: Appointments for this test are only available on Mondays.
View My Booking
Sample Type Blood
Turnaround 15 Days
Available Booking Days Mondays Only

This panel is for individuals with a personal or family history of venous thromboembolism (VTE), recurrent miscarriage, or unexplained clotting at a young age, where an inherited thrombophilia is suspected. It uses polymerase chain reaction (PCR) and hybridisation techniques to detect common genetic variants that predispose to excessive clot formation. Identifying these variants helps your doctor assess your baseline thrombotic risk and tailor preventive strategies, particularly around surgery, pregnancy, or hormonal therapy.

Coagulation Factor Variants
- Factor II (G20210A): the prothrombin gene variant linked to elevated prothrombin levels and increased clotting tendency
- Factor V (G1691A, also known as Factor V Leiden): the most common inherited thrombophilia, causing resistance to activated protein C
- Factor V (R2 H1299A): a secondary Factor V haplotype that can further modify clot risk when combined with other variants

Methylation and Fibrinolysis Variants
- MTHFR (C677T, A1298C): variants affecting homocysteine metabolism, which may contribute to endothelial dysfunction and thrombotic risk
- PAI-1: a polymorphism influencing plasminogen activator inhibitor-1 levels, potentially reducing the body's ability to break down clots
- Factor XII (V34L): a common variant that may have a mild protective or modifying effect on clot formation

Endothelial Protein C Receptor Variants
- EPCR (A1, A3): haplotypes affecting the protein C anticoagulant pathway, which may influence thrombotic tendency

Why it matters
Knowing your inherited thrombophilia profile allows for personalised risk management. If a significant variant is found, your doctor can discuss targeted precautions such as avoiding combined oral contraceptives, using prophylactic anticoagulation during high-risk periods, or arranging enhanced monitoring in pregnancy. For many people, a negative result provides reassurance that a genetic cause is unlikely, guiding the search for acquired or lifestyle-related factors.

Coagulation Factor Variants
- Factor II (G20210A)
- Factor V (G1691A, R2 H1299A)

Methylation and Fibrinolysis Variants
- MTHFR (C677T, A1298C)
- PAI-1
- Factor XII (V34L)

Endothelial Protein C Receptor Variants
- EPCR (A1, A3)

No special preparation required.

For blood tests, we recommend drinking plenty of water beforehand to ensure smooth sample collection. If you are taking any regular medication, continue to do so unless advised otherwise by your doctor.

Important Clinical Information:

This test is a screening tool to monitor and support your overall health. It does not replace your GP or Consultant.

Always discuss your test results, especially any abnormal results, with your GP, who can interpret them in the context of your medical history and overall health.

Service Booking
15 min
£400
305 Neasden Lane, London NW10 1QR, UK

No additional fees

View My Booking